US Earnings Financial Results SEC Filings — October 13, 2026

13-10-2026

Arts-Way Manufacturing's 10-Q for the quarter ended August 31, 2026 shows nine-month sales up 12.3% YoY to $20.1M, but third-quarter sales fell 12.7% YoY to $5.6M and the company swung to a net loss of $139,720 (vs. net income of $254,110 a year earlier). Nine-month net income declined 86.3% to $230,200, as prior-year results were boosted by a $1.37M employee retention credit and other non-operating gains.

• · Q3 FY26 general and administrative expenses rose 22.8% YoY to $1.21M, the main driver of the swing to an operating loss.
• · Nine-month FY25 other income of $1.53M was largely the employee retention credit ($1.62M across segments on a consolidated basis), which did not recur in FY26 at a comparable level, depressing pre-tax income by roughly $1.2M YoY.
• · Receivables rose to $5.07M from $2.20M at fiscal year-end, while billings in excess of cost increased to $3.35M from $0.43M, indicating larger customer advances and working-capital shifts.
• · Line of credit increased to $3.65M from $3.25M, and the company recorded $222,090 of financed insurance premiums, a new non-cash item in current assets.
• · Cash was essentially flat at $2,855 at period end, with liquidity dependent on the revolving line of credit.
• · Q3 FY26 interest expense rose 36% YoY to $113,734, and nine-month interest expense increased 30% to $337,558.

13-10-2026

CYBRIATECH INC reported a net loss of $5,339 for the three months ended August 31, 2026, versus a net loss of $11,552 in the prior-year quarter, while revenue fell to $2,320 from $9,000 (-74%). For the nine months ended August 31, 2026, the company posted net income of $598 versus a net loss of $24,009 a year earlier, but this turnaround was driven by lower G&A expenses ($29,402 vs. $57,676) rather than revenue growth, as nine-month revenue declined to $30,000 from $33,667 (-11%). Total stockholders' deficit narrowed to $(29,611) from $(30,209) at fiscal year-end, and cash rose to $11,549 from $1,185, supported by $6,000 in related-party financing.

• · Nine-month net income of $598 reflects a $(2,759) loss in Q1 FY26 and an $8,696 profit in Q2 FY26, followed by the $(5,339) loss in Q3 FY26
• · Accumulated deficit narrowed to $(30,211) from $(30,809) at November 30, 2025
• · Total current liabilities rose to $43,502 from $42,771, with related-party payables increasing to $17,843 from $11,843
• · Right-of-use asset fully amortized to zero ($8,928 at fiscal year-end), with lease liability reduced to $5,000 from $8,928
• · Operating cash flow of $4,364 for the nine months, versus $(4,718) used in the prior-year period, though this was supported by a $8,928 non-cash right-of-use amortization add-back
• · Company has 6,000,000 shares outstanding and zero income tax expense in all periods presented
• · Cash paid for taxes of $500 in the nine months ended August 31, 2025 with none in 2026

13-10-2026

Zhanling International Ltd (ZLME) reported a net loss of $6,597 for the three months ended August 31, 2026, versus $8,126 in the prior-year quarter, a 18.8% reduction in losses, with general and administrative expenses as the sole operating cost. The company holds no cash, total assets of $3,404 (all prepayments), and a stockholders' deficit that widened to $(59,636) from $(53,039) at May 31, 2026, with total liabilities rising to $63,040 driven by new amounts due to related and non-related parties. The filing shows continued going-concern-type financial stress, with the balance sheet relying on related-party funding to cover expenses.

• · Cash balance was zero at both August 31, 2026 and 2025; all operating costs were funded by related and non-related party advances and expenses paid on the company's behalf.
• · Weighted average shares outstanding rose about 23.7% year over year (2,782,000 to 3,441,000), reflecting conversion of payables to equity of $12,368 in the current quarter.
• · Current-period liabilities shifted from non-current to current: $46,900 of non-current related/non-related party debt at May 31, 2026 is now classified as current due to related parties ($53,668) and non-related parties ($5,600).
• · Prepayments rose from $183 to $3,404, consuming operating cash flow adjustments of $3,221 in the quarter.

13-10-2026

OZ Vision Inc. (UNXP) reported sales of $46,930 for the fiscal year ended June 30, 2026, down 13.5% from $54,232 in FY2025. Cost of goods sold fell 38.1% to $33,846, lifting gross profit to $13,084 from a loss of $(460) in the prior year. However, total operating expenses rose 10.2% to $71,755, and the net loss narrowed only slightly to $(58,671) from $(65,601), a 10.6% improvement. Revenue declined while expenses increased, leaving the company with minimal cash and continued losses.

• · Advisory and consultancy fees of $18,185 in FY2025 were eliminated entirely in FY2026.
• · General and administrative expenses rose roughly 73.6% to $39,994 from $23,043, the largest driver of higher operating costs.
• · OTC market and registration fees increased 38.7% to $12,761 from $9,200.
• · Temporary storage fees of $19,000 in FY2026 were incurred, versus $14,713 in FY2025.
• · Operating cash flow turned positive at $4,335 versus $(15,549) in FY2025, driven by a $63,006 increase in payables; the company remains dependent on payables and has no financing inflows.
• · Total current liabilities of $1,204,517 far exceed cash of $4,388, indicating a severe liquidity shortfall.
• · Intangibles of $13,098,890 make up roughly 95% of total assets and were unchanged, so asset value depends on the valuation of intangibles rather than cash generation.
• · Net loss per share is reported as $0 given 29,372,951 weighted average shares, and no shares were issued during the period.
• · The 3-year pay-versus-performance table shows a total shareholder return index of 158.23 in 2026, up from 87.97 in 2025, while net losses persisted.

13-10-2026

Domino's Pizza (DPZ) reported fiscal Q3 2026 total revenues of $1,185.6 million, up 3.4% YoY from $1,147.1 million, and net income of $152.2 million, up 9.2% from $139.3 million; diluted EPS rose to $4.60 from $4.08 (+12.7%). However, U.S. Company-owned store revenue fell 25.8% YoY to $61.4 million, U.S. franchise advertising revenue declined 2.3%, and the company's stockholders' deficit widened to $3,955.1 million while current liabilities surged to $1,879.5 million, driven by $1,326.8 million of debt reclassified as current.

• · Current portion of long-term debt jumped to $1,326.8M from $6.1M, which drives the 247% rise in current liabilities; this maturity/refinancing need is a key liquidity watch item
• · Investment in DPC Dash fell 58% from $36.1M to $15.2M after $20.9M of YTD unrealized/realized losses, a negative drag on other income (-$20.9M YTD vs +$5.0M prior year)
• · Three-quarter operating cash flow declined 5.7% to $520.6M, while cash used in financing rose to $451.7M, largely from share buybacks and dividends
• · Interest expense rose to $138.5M YTD from $135.2M, and interest income fell to $6.2M from $11.8M
• · Dividends payable increased to $67.6M from $2.7M, signaling a timing-driven rise in declared dividends at quarter-end
• · Net income growth outpaced revenue growth partly due to a $7.8M YTD gain on asset sales and $3.9M refranchising gain, which are non-recurring in nature

13-10-2026

Nurix Therapeutics reported Q3 FY2026 (three months ended August 31, 2026) total revenue of $673.1M, driven by a $653.2M license revenue recognition, versus $7.9M in the prior-year quarter, producing net income of $549.8M (EPS $4.93 basic) compared with a net loss of $86.4M a year earlier. Nine-month revenue rose to $688.4M from $70.4M and net income reached $373.1M versus a $186.2M loss, though underlying collaboration revenue declined 13% over nine months ($35.2M vs $40.4M) and R&D spending in the quarter fell 8% year over year.

• · Q3 FY2026 net income of $549.8M was driven almost entirely by $653.2M in license revenue, a non-recurring item, against a $91.4M operating loss in the prior-year quarter's comparable period
• · Nine-month collaboration revenue declined 13% to $35.2M, and nine-month R&D expense rose 7.3% to $251.0M, offsetting part of the top-line improvement
• · Accumulated deficit narrowed to $(630.1)M from $(1,003.2)M, and Q3 G&A expense rose 161% year over year to $34.4M
• · Deferred collaboration funding liabilities totaled $45.6M in new cash inflows during the nine months, and $20.0M in accounts receivable was recorded
• · Issued 1.0M shares via ATM financing for net proceeds of $18.0M during the nine months

13-10-2026

Norris Industries, Inc. (NRIS) reported Q2 FY2027 (three months ended August 31, 2026) revenue of $85,005, up 0.7% YoY from $84,388, while net loss widened 6.2% to $161,303 from $151,889. For the six months ended August 31, 2026, revenue declined 1.0% to $175,363 and net loss rose 26.4% to $403,621, with stockholders' deficit growing to $5,252,352 and total liabilities of $5,476,066 against total assets of $223,714. Cash rose to $134,836 from $45,376 at fiscal year-end, funded largely by $400,000 in related-party loans.

• · Oil sales were nearly flat YoY in Q2 (+0.1%), while natural gas sales rose 2.7% in Q2 but fell 27.3% over six months.
• · Accounts payable and accrued expenses - related parties (long-term) rose to $825,091 from $756,683; asset retirement obligations fell to $307,267 from $416,334.
• · Cash flow from operations used $310,540 over six months, funded by $400,000 in related-party loans; the company is dependent on related-party financing.
• · Management's stated plan is a financed acquisition of mature smaller oil fields with EOR potential and/or acquisitions of profitable energy operators to achieve positive cash flows.
• · Depletion, depreciation, and accretion expense fell sharply to $11,576 for six months from $23,582, reflecting a shrinking oil and gas property base (net $62,630 vs. $183,273 at fiscal year-end).

13-10-2026

EON Resources Inc. reported a Q1 2026 net loss of $5,772,595 (about $0.11 per share) on total revenues of $968,193, versus a restated Q1 2025 net loss of $2,027,984 attributable to EON and total revenues of $4,505,098. Crude oil revenue was roughly flat at $4,384,267 versus $4,392,605, but a $3,579,475 loss on derivative instruments drove the revenue decline, and operating loss widened to $6,203,346 from $4,158. Cash fell to $129,772 from $375,036 and total liabilities rose to $41,087,079 from $36,691,287, while total stockholders' equity declined to $48,856,323 from $52,987,299.

• · Q1 2026 included $3,579,475 loss on derivative instruments, net, which more than offset crude oil revenue and was the primary cause of the revenue decline.
• · Depletion, depreciation and amortization rose to $1,790,976 from $97,075 in Q1 2025, a major driver of the operating loss.
• · Accounts payable rose to $9,139,085 from $8,351,450 at December 31, 2025, and revenue and royalties payable rose to $5,978,024 from $5,028,415.
• · Short-term and long-term hedging derivative liabilities totaled $2,683,479 and $526,638 at March 31, 2026, with no comparable balances at December 31, 2025.
• · Net cash used in operating activities was $305,976 in Q1 2026 versus $1,827,355 in Q1 2025, an improvement in operating cash burn.
• · Net cash provided by financing activities was $1,149,502 in Q1 2026, funded mainly by $1,692,000 in convertible note proceeds and $100,000 in related party loans.
• · The filing discloses a restatement of Q1 2025 and December 31, 2024 financials, which affects comparability of prior-period figures.
• · The filing is labeled as a 10-Q dated October 13, 2026 but covers the quarter ended March 31, 2026, implying a significantly delayed filing.

13-10-2026

MADE IN USA INC. (ALXYD) reported no sales for the three and six months ended August 31, 2026, versus $24,460 and $35,936 in the comparable 2025 periods, a decline of 100% in both periods. Net loss was $(1,737) for the quarter and $(4,724) for the six months, compared with net income of $8,665 for the prior-year quarter and a net loss of $(22,861) for the prior-year six months. The company acquired intangible/software technology assets valued at $25,000,000 by issuing 5,000,000 shares to a common-control party, which now make up nearly all of total assets of $25,089,081.

• · Net cash used in operating activities for the six months ended August 31, 2026 was $(25,000,000), driven by a $(25,000,000) increase in assets in progress, offset by a $25,000,000 investing inflow classified as an intangible asset.
• · Cash balance was zero at both August 31, 2026 and February 28, 2026, with no cash paid for interest or income taxes.
• · The company carries a $622 related-party loan as its only liability.
• · Net operating loss carryforward of $67,834 generates a deferred tax asset fully offset by a valuation allowance, resulting in zero income tax expense.
• · Accumulated amortization on intangible assets rose to $15,139 from $11,665, while net intangible assets (excluding the acquired $25.0M asset) are minimal.

13-10-2026

National Rural Utilities Cooperative Finance Corp (CFC) reported Q1 FY2027 net income of $135.4 million, up from $4.7 million in Q1 FY2026, driven mainly by a swing in derivative gains to $96.6 million from a $32.2 million loss. However, adjusted net income fell 7.5% to $52.8 million from $57.2 million, adjusted TIER declined slightly to 1.15 from 1.16, and adjusted net interest income decreased 1.4% to $90.0 million from $91.2 million.

• · Net interest yield improved to 0.78% from 0.75%, while adjusted net interest yield declined to 0.93% from 0.96%.
• · Adjusted net interest spread compressed to 0.63% from 0.68%, reflecting lower asset yields and a reduced derivative cash settlement benefit (-$14.0M vs -$20.3M).
• · Interest income on cash and investment securities fell 21.9% YoY to $1.3M from $1.9M, while line of credit loan interest income declined 15.8% YoY to $59.4M from $70.6M.
• · Medium-term notes average balance rose 18.9% YoY to $12.8B, becoming the largest funding source and a key driver of higher interest expense.
• · Guaranteed Underwriter Program notes payable declined 17.4% YoY on average balance, reducing that funding cost category.
• · Derivative forward value gains of $82.6M compared with losses of $52.5M in the prior year, the primary driver of the net income swing; these are non-cash and excluded from adjusted net income.

13-10-2026

ANVI GLOBAL HOLDINGS, INC., a shell-like company with no revenue, reported a net loss of $57,846 for the three months ended August 31, 2026, up 1.5% from $57,022 in the prior-year quarter, and a net loss of $110,707 for the six months, up 5.2% from $105,270. Cash fell to $250 from $1,855 at fiscal year-end, and the stockholders' deficit widened to $(2,471,606) from $(2,360,899), with total liabilities of $2,475,981 driven largely by related-party payables and advances from an officer.

• · The company reported no revenue in either period; all expenses are general and administrative, and the company is classified as a shell company for reporting purposes.
• · Related-party obligations (accounts payable to related party of $864,000 and accrued related-party liabilities of $900,000) make up a large share of total liabilities, and the company depends on advances from an officer to fund operations.
• · Cash of $250 against $2,475,981 in total liabilities indicates the company has minimal liquidity and is reliant on continued related-party funding.
• · Net cash used in operations declined YoY, but this reflects lower cash-based spending rather than improved operating performance, since the net loss increased.

13-10-2026

MedWellAI, Inc. (MWAI) filed its annual report on Form 10-K for the fiscal year ended June 30, 2026. The filing discloses the terms of its Series C Preferred Stock under an amended and restated certificate of designation, which carries as-converted dividend and voting rights, liquidation preference at Stated Value plus accrued dividends, and conversion at the prior day's closing price. Reported total other expense rose to $(283,477) from $(109,126), driven by a $(241,918) loss on exchange of Series C and D preferred shares, while commissions revenue declined to $437,857 from $576,931. Total revenue-type income fell to $527,857 from $594,768, and the company flags penny-stock and share-price volatility risks.

• · Commissions revenue fell 24.1% and online sales dropped to zero, while rental income of $90,000 appeared as a new line item.
• · Total other expense more than doubled (+159.6%), led by a $241,918 loss on exchange of Series C and D preferred shares.
• · The 2024 Equity and Incentive Plan, not approved by stockholders, has 850,000 shares remaining available for future issuance with no outstanding options or warrants.
• · Series C Preferred dividends and liquidation preference are tied to Common Stock dividends and Stated Value, and conversion uses the prior trading day's closing price, creating potential dilution sensitivity to share price.

13-10-2026

Solitron Devices reported Q2 FY2027 (three months ended August 31, 2026) net sales of $5,657 thousand, up 41.9% from $3,986 thousand in the prior-year quarter, with net income of $1,298 thousand versus a net loss of $234 thousand a year earlier. For the six months ended August 31, 2026, net sales rose 66.0% to $11,093 thousand and net income was $2,288 thousand versus a $570 thousand loss. However, total other income (loss) for the six months swung to a $137 thousand loss (from a $108 thousand loss), driven by a $333 thousand contingent consideration expense, and realized losses on investments of $80 thousand.

• · Net income per share was $0.60 for the quarter versus a $(0.11) loss a year earlier, and $1.06 for the six months versus $(0.27).
• · Operating cash flow was $3,601 thousand for six months versus $777 thousand a year earlier, but inventories rose $1,197 thousand (cash outflow) versus a $142 thousand inflow in the prior year.
• · Contingent consideration expense of $333 thousand in the six months (vs. none prior year) is a non-recurring drag on other income, with a $2 thousand expense in the quarter.
• · Realized losses on investments of $(80) thousand in the quarter (vs. $170 thousand gain prior year) and the company holds no marketable securities at August 31, 2026, versus $2 thousand at February 28, 2026.
• · Income tax expense rose to $(825) thousand for six months versus a $207 thousand benefit prior year, reflecting a shift to profitability and a deferred tax change of $825 thousand.
• · Interest expense declined to $(107) thousand for six months from $(140) thousand, and interest income rose to $136 thousand from $42 thousand.

13-10-2026

OKMIN Resources' 10-K for fiscal year ended June 30, 2026 shows total assets declining to $87,897 from $133,322 a year earlier (about -34%), driven by the removal of the Black Rock Joint Venture (carried at $68,084 in 2025) while oil and gas properties grew to $65,654 from $53,713 (+22%). Stockholders' deficit widened to $(642,779) from $(620,605), accumulated deficit rose to $(2,672,984), and current liabilities remained high at $730,676, with accrued related-party liabilities up to $600,750 from $438,750. Cash increased to $22,178 from $11,488, but the balance sheet remains heavily stressed and the company continues to rely on equity issuances for services and debt conversions.

• · Black Rock Joint Venture is no longer carried on the balance sheet (68,084 in 2025 to nil in 2026), and its revenue fell from 20,294 to 1,268, indicating a disposal or deconsolidation.
• · Oil production from Black Rock JV fell from 328 barrels to 21 barrels year over year, and Pushmataha gas production rose from 811 to 2,360.43 MCF in the disclosed table, with mixed unit basis between tables.
• · Vitt Lease generated no revenue in FY2026 versus 354 in FY2025 (5.44 barrels of oil in FY2025).
• · Equity issuances for services and debt conversion continued, including 6,503,024 shares issued to settle a convertible note and 1,000,000 shares issued to a corporate advisor in March 2026.
• · Cash raised from private placements was small: 30,000 in September 2025 and 54,000 in March 2026, at $0.03 per share.
• · Current liabilities remain well above total assets, leaving a working capital deficit of roughly 708,433 at June 30, 2026.

13-10-2026

Escalon Medical Corp reported FY2026 (year ended June 30, 2026) net revenue of $12.74M, up 5.7% from $12.05M, driven by a 4.9% rise in product revenue to $12.08M and a 22.9% jump in service plan revenue to $0.65M. Cost of revenue rose to 56.3% of revenue from 54.3%, and operating income fell to $45K from $133K, weighed down by higher marketing, general and administrative expenses (up 8.6%). Net income of $4.01M was driven by a one-time $2.81M gain from the sale of AXIS software and a $1.14M deferred tax benefit, and liquidity improved sharply, with the current ratio rising to 2.94 from 1.72 and cash climbing to $3.07M.

• · Cost of revenue as a share of revenue rose about 2 percentage points to 56.3%, compressing gross margin.
• · Operating income fell about 66% to $45K despite higher revenue, as MG&A and cost of revenue grew faster than sales.
• · Net income applicable to common stockholders was $2.01M after $1.95M allocated to convertible preferred stock and $51.6K of undeclared preferred dividends.
• · Inventories fell 19% and accounts payable fell 33%, indicating working capital management shifts alongside the cash build.
• · Lease liabilities and right-of-use assets rose sharply, with ROU assets up to $827K from $254K, reflecting new leases.
• · Accumulated deficit narrowed to $(64.4M) from $(68.4M), reflecting the FY2026 net income.

13-10-2026

AZZ Inc. reported Q2 FY2027 (three months ended August 31, 2026) sales of $486.9M, up 16.7% from $417.3M a year earlier, with operating income rising 22.4% to $83.8M and diluted EPS of $1.94. However, net income fell 34.6% to $58.5M, as the prior-year quarter included a $59.3M equity-method contribution from the AVAIL joint venture that was largely absent in the current period, and diluted EPS declined from $2.95. For the six months, sales rose 11.5% to $935.4M while net income fell 57.6% to $110.5M, reflecting the same non-recurring AVAIL distribution comparison in the prior year.

• · Q2 FY2026 net income was inflated by a $59.3M equity-method contribution and a $273.2M six-month AVAIL JV distribution in the prior year; the current period shows only $6.8M in equity earnings, making year-over-year net income comparisons misleading on an operating basis.
• · Investment in AVAIL joint venture fell from $19.96M to $11.46M, with $15.7M in return-of-investment proceeds received in the six months ended August 31, 2026.
• · Interest expense, net declined 20.9% for the six months (from $32.2M to $22.1M) and 20.9% for the quarter (from $13.7M to $10.8M), supporting operating results.
• · Working capital build weighed on operating cash flow: changes in current assets and liabilities consumed $31.3M in the six months versus $5.7M a year earlier; inventories rose 18.2% and trade receivables rose 25.5% since February 28, 2026.
• · A new acquisition closed July 30, 2026 for $57.5M net of cash acquired, producing $25.9M of goodwill, $20.0M of intangibles and other assets, and $29.3M of right-of-use assets matched by lease liabilities.
• · Q2 FY2027 dividend declared rose to $0.24 per share from $0.20, and six-month dividends totaled $0.44 versus $0.37.
• · Cash on hand is thin at $1.95M, with Revolving Credit Facility net repayments of $35.0M in the six months.

13-10-2026

Advanced Biomed Inc. (ADVB) reported its fiscal 2026 annual results (year ended June 30, 2026) with first revenue of US$127,637 versus nil in FY2025, but a continuing-operations loss before taxes of US$6,262,481 (up 476% from US$1,086,470) driven by stock-based compensation of US$1,734,009 and G&A expenses up 326% to US$4,627,170. Net income for the year swung to US$6,677,077 from a loss of US$3,258,969, but this was entirely due to a US$14,015,417 gain on disposal of subsidiaries; the company's core operations remained loss-making. Cash declined by US$2,518,380 to US$385,535, while net current assets rose to US$12,275,523 largely from prepaid expenses and other current assets.

• · Operating cash burn from continuing operations was US$961,341, with US$2,581,850 used in continuing investing activities funded by US$1,326,215 of financing inflows.
• · Other comprehensive loss from foreign currency translation was US$(372,814) in FY2026 versus a gain of US$218,346 in FY2025.
• · Basic and diluted EPS was US$5.33 for FY2026 (continuing operations US$(5.00)) versus US$(3.18) in FY2025 (continuing operations US$(1.06)).
• · Shares outstanding rose from 1,082,000 to 1,652,133 as of June 30, 2026.
• · Management indicates regulatory approvals for early cancer detection products may be delayed, limited, or never obtained, which could impair revenue generation.
• · FinTruth is in Stage II (months 3-6, in progress), with 5-10 pilot or proof-of-concept engagements underway or under discussion with commercial banks and fintech firms, not yet converted to paying recurring revenue.

13-10-2026

Park Aerospace reported strong fiscal Q2 2027 results (13 weeks ended August 30, 2026) with net sales up 26.9% YoY to $20,791 thousand and net earnings up 88.6% YoY to $4,534 thousand, though the 26-week period showed growth of 23.0% in net sales and 79.9% in net earnings. Gross margin expanded to 34.3% from 31.2% in the prior-year quarter, while SG&A rose only 5.8%. Cash and marketable securities increased substantially, largely funded by a $26,264 thousand stock issuance, while operating cash flow for the 26-week period turned positive at $1,270 thousand versus a $527 thousand outflow a year earlier. Figures are reported in thousands of USD as presented in the filing.

• · Cash and cash equivalents rose from $78.5M to $98.3M, while total cash, equivalents and marketable securities reached about $114.7M
• · Accounts receivable grew 35.2% and inventories grew 20.9% since March 1, 2026, a working capital build that absorbed $7.8M in operating cash flow for the 26-week period
• · Finished goods inventory nearly doubled from $695K to $1,290K (+85.6%)
• · Cash paid for income taxes fell to $2.2M from $6.2M in the prior-year 26-week period
• · Purchases of marketable securities of $9.9M exceeded proceeds from sales and maturities of $4.5M in the 26-week period, versus the prior year when sales/maturities of $18.0M exceeded purchases of $2.4M
• · Capital expenditures were modest at $469K for 26 weeks, down from $664K a year earlier
• · Interest and other income more than doubled to $839K in Q2 from $390K, contributing meaningfully to pre-tax earnings growth
• · Effective tax rate for Q2 was approximately 18.6% versus 25.7% in the prior-year quarter

13-10-2026

Worthington Steel reported a three-month net loss attributable to the controlling interest of $(10.0) million for the quarter ended August 31, 2026, versus net earnings of $36.8 million a year earlier, a swing of roughly 127%. Net sales rose to $2,726.6 million from $872.9 million (up about 212% YoY), driven by a large acquisition that also lifted total assets to $6,021.9 million and long-term debt to $1,654.8 million, while interest expense climbed to $38.8 million from $2.9 million and earnings per share turned to $(0.20) diluted from $0.73.

• · Inventories rose to $1,710.4 million from $415.7 million, with raw materials up sharply to $935.9 million from $168.5 million, reflecting acquired inventory.
• · Cash and cash equivalents increased to $248.2 million from $84.6 million, but cash used in operating activities was $(6.0) million, with the increase funded by $1,568.7 million of new long-term debt.
• · Accounts payable increased to $1,170.8 million from $424.0 million, and receivables rose to $1,387.2 million from $496.2 million.
• · Noncontrolling interests grew to $604.2 million from $134.3 million, and net earnings attributable to NCI were $5.0 million versus $1.8 million a year earlier.
• · Accumulated other comprehensive loss swung to $(15.6) million from $3.9 million, driven by foreign currency translation losses of $(23.4) million.
• · Realized loss on equity investment of $15.5 million and a $(16.7) million equity-method adjustment weighed on non-operating results.
• · Prepaid pension assets of $332.7 million appeared on the balance sheet, versus none at May 31, 2026.
• · Net loss from discontinued operations was $(4.9) million, with $180.1 million in current assets and $108.4 million in current liabilities classified as discontinued.
• · Dividend payments remained steady at $0.16 per share, totaling $8.2 million paid.

13-10-2026

Shreya Acquisition Group, a SPAC incorporated June 25, 2025, filed its first annual report for the fiscal year ended June 30, 2026, reporting net income of $372,145 driven by $546,613 of trust account interest income, against G&A costs of $214,968. The company holds $110,546,713 in its Trust Account following its IPO, with total assets of $111,477,991 and total shareholders' equity of $160,873. Year-over-year comparisons are limited because the prior period covers only inception through June 30, 2025, which recorded a net loss of $6,665.

• · Net income is entirely attributable to trust interest income and the over-allotment liability gain; operating costs exceeded zero operating income, with loss from operations of $214,968
• · Net cash used in operating activities was $166,886, while the company still holds $840,520 in unrestricted cash
• · Redeemable share EPS and non-redeemable share EPS are both reported at $0.06 for FY2026, with 1,627,397 weighted redeemable shares and 4,748,571 weighted non-redeemable shares
• · Sponsor Thews (Mauritius) Limited receives $5,000 per month for office space and administrative support, and holds 191,750 private placement units bought for $1,917,500
• · Deferred underwriting commissions of $600,000 remain a liability, payable on a business combination

13-10-2026

NightFood Holdings' annual report for the fiscal year ended June 30, 2026 shows revenue rising to $8,127,029 from $482,285, driven by newly acquired hotel operations, but a $63,886,000 goodwill impairment drove the net loss to $84,654,946 versus $8,115,878 in the prior year. Management flags substantial doubt about the company's ability to continue as a going concern, a working capital deficit of $29,761,991, and $7,049,557 of principal in default at June 30, 2026. Revenue growth is substantial, but the results are overwhelmingly negative on profitability, liquidity, and dilution risk.

• · Hotel operations posted an operating loss before impairment of $(2,463,030) reflecting stabilization-period occupancy, renovation disruption, and above-forecast property costs
• · Non-cash charges tied to stock price, including derivative fair value changes and stock-based compensation, were a substantial share of the pre-impairment loss
• · Convertible notes convert at the lower of $0.033/share or 80% of recent trading prices, creating significant potential dilution
• · Foodservice packaging revenue was $1,609,016 versus $466,633 in FY2025, which reflected only one quarter of SWC ownership
• · Shares issued on note conversions and warrant exercises relied on Section 3(a)(9) exemptions, and private placements relied on Section 4(a)(2) and Rule 506(b)

13-10-2026

Lunai Bioworks Inc. (LNAI) filed its annual report on Form 10-K on October 13, 2026, disclosing substantial doubt about its ability to continue as a going concern and stating it does not believe its cash and cash equivalents are sufficient for the next twelve months, with less than one month of available cash resources as of October 13, 2026. The company describes itself as a pre-clinical-stage AI-based biotechnology company with no products approved by regulators, and it reported a material weakness in internal control over financial reporting as of June 30, 2026.

• · Company may be unable to maintain Nasdaq Capital Market continued listing requirements, risking delisting of its Common Stock
• · Conversion of Series B Convertible Preferred Stock would cause substantial dilution, and Series B ranks senior to Common Stock on liquidation
• · Company relies on licensed intellectual property, and disruption of licensing relationships could severely affect operations
• · Company's ability to fund operations depends on substantial additional financing, with potential dilution from equity issuances and equity incentive plans

13-10-2026

Visium Technologies, Inc. (VISM) filed its 10-K for the fiscal year ended June 30, 2026, reporting net income of $856,102 versus a net loss of $(1,341,979) in FY2025, driven largely by a $2,923,004 gain on extinguishment of debt. Cash fell to $22,212 from $60,144 (-63%), net cash used in operations widened to $(913,888) from $(411,177), and the filing discloses substantial dilution with roughly 1.27 billion common shares outstanding plus about 1.32 billion potential common shares. Interest income declined 100% to zero, and the filing carries a going-concern disclosure.

• · Net income of $856,102 was achieved only because of a $2,923,004 gain on extinguishment of debt; operating cash burn still worsened by 122% to $(913,888).
• · Cash balance fell 63% to $22,212 while the company relied on $875,956 of net financing inflows, including $528,000 of short-term note proceeds.
• · Accrued compensation dropped 96.5% to $89,158, largely due to the settlement of $2,834,819 of obligations in 40,000,000 common shares.
• · Potential dilution is severe: 1,269,509,667 common shares outstanding plus 1,320,167,346 potential common shares from preferred, dividend and convertible note conversions.
• · Common shares were issued at $0.00075 per share (500,000,000 shares for $375,000 cash) in April 2026, indicating very low equity pricing.
• · Interest income declined to zero from $12,767, and the filing includes a going-concern disclosure given the cash position and operating cash burn.
• · A risk factor section highlights exposure to economic, political, currency and expropriation risks from global and emerging-market operations.

13-10-2026

Treasure Global Inc reported total revenues of $5,169,784 for the fiscal year ended June 30, 2026, up 121.8% from $2,330,557 in FY2025, driven almost entirely by product and loyalty program revenue of $5,157,597 (up 732.0%), while customized software development revenue fell to zero from $1,480,000 and member subscription revenue declined 100.0%. Gross profit collapsed 99.5% to $8,742 (0.2% gross margin versus 71.6% a year earlier), and the net loss attributable to shareholders narrowed to $(11,085,040) from $(23,377,488), a 52.6% improvement that was largely aided by a $4,643,137 gain on derivative fair value changes and a $1,013,977 gain on disposal of subsidiaries rather than operating performance, which deteriorated as operating expenses fell 30.7% to $16,435,069 but loss from operations still totaled $(16,426,327).

• · Management flags a limited cybersecurity incident in May 2025 and warns events could recur
• · A limited number of customers account for a meaningful share of revenues, receivables and prepayments
• · Company has not paid dividends and does not expect to
• · Accumulated deficit grew to $(72,492,602) from $(61,407,562)
• · Weighted average shares fell to 1,151,060 from 58,836 and loss per share improved to $(9.63) from $(397.33), reflecting a large share count increase
• · Current-year gross margin on product and loyalty revenue was negative (-0.1%) versus 66.8% prior year

13-10-2026

Thunder Power Holdings (AIEV) reported no revenue for the three and six months ended June 30, 2026, with a net loss of $431,424 for Q2 2026 (vs. $503,503 in Q2 2025, a 14% decrease) and $925,075 for the six months (vs. $1,258,406, a 26% decrease). Operating expenses declined year-over-year, but the company recorded a new $81,004 equity-method share of loss and interest expense rose sharply, while liquidity remains constrained and reliant on related-party borrowings.

• · Equity issuance of 31,872,768 shares (~$5.7M equity; $6.37M non-cash) for an equity-method investee drove shareholders' equity to $9.63M, despite zero revenue
• · Cash fell to $11,649 at June 30, 2026, versus $97,454 a year earlier (down ~88%), with operations funded by $522,000 of related-party borrowings
• · Going-concern-style disclosures flag operating losses, liquidity constraints, and a prepaid forward contract whose realization is highly uncertain and not expected to generate near-term cash
• · Foreign currency adjustments swung to a $1,046 gain for six months 2026 versus a $3,228 loss a year earlier; TWD/USD balance sheet rate moved to 31.85 from 31.37

13-10-2026

Eagle Nuclear Energy Corp. (NUCL) reported its 10-Q for the quarter ended August 31, 2026, showing a net income of $4,345,941 for the three months, driven by an $8,075,000 non-cash gain from the change in fair value of its warrant liability, versus a net loss of $1,282,331 a year earlier. However, for the nine months the company posted a net loss of $22,187,888 (vs. $2,974,432 prior year), with operating expenses up sharply to $12,494,357 from $2,964,817, and total stockholders' equity moved to a deficit of $2,275,855 from equity of $1,689,357 at November 30, 2025. Cash rose to $25,466,623 following a $29,700,000 PIPE financing and a reverse recapitalization, while the company completed the acquisition of Oregon Energy LLC and issued Series A Preferred Stock carrying accruing dividends.

• · Operating loss widened sharply: the company reported $0 revenue and its nine-month operating expenses rose more than fourfold year-over-year, with G&A accounting for most of the increase
• · Operating cash burn increased about 112% to $7,341,171 for the nine months, despite a $29.7M PIPE raise
• · Warrant liability of $13,850,000 is a material non-cash item that drove the nine-month loss and could produce further volatility in future periods
• · Stock-based compensation of $6,080,147 for the nine months was a major non-cash expense
• · Series A Preferred dividends are accruing (paid-in-kind of $937,381 plus $772,230 accrued and payable), and Series A is redeemable beginning February 24, 2031
• · Mineral rights carry the Aurora Uranium Project, which is exploration-stage with no assurance of commercially exploitable reserves; the company has not yet earned revenue from it, per the filing's risk factor disclosure

13-10-2026

Birdie Win Corp (BRWC) filed its 10-K for the fiscal year ended July 31, 2026, reporting revenue of $20,000, down 33.3% from $30,000 in FY2025, and a net loss of $27,474, widening 58.8% from $17,299. Total assets fell to $10,294 from $19,570 and stockholders' equity turned negative at $(13,104) versus $14,370 a year earlier, while the company relied on $18,198 of advances from a director to fund operations. Cash rose modestly to $5,820 from $2,171, although operating cash outflow was $(14,549) compared with an inflow of $326 in the prior year.

• · Accumulated deficit grew to $(102,669) from $(75,195), reflecting cumulative losses over the period
• · Net cash used in operating activities of $(14,549) was partially offset by $18,198 in director advances, the sole financing source
• · Stock-based compensation to consultants of $14,000 (related-party G&A) was a non-cash expense in FY2026, versus $10,000 in FY2025
• · Prepayments fell to $4,474 from $17,399, including nil related-party prepayments versus $14,000 the prior year
• · Plant and equipment is fully depreciated ($2,231 cost, $2,231 accumulated depreciation) with no net book value in either period
• · Share count unchanged at 6,720,000; no proceeds from share issuance in either year, while FY2025 included $24,000 of stock issued to a service provider
• · Entire pre-tax loss is attributed to local jurisdiction; no Hong Kong tax expense recorded

13-10-2026

Wenyuan Group Corp. (WYGC) reported zero revenue for the three and six months ended June 30, 2026, with a net loss of $52,416 for Q2 2026 (vs. $78,819 in Q2 2025) and $116,090 for the six months (vs. $164,779). Total liabilities rose sharply to $183,787 from $86,624 at December 31, 2025, driving total stockholders' deficit to $(129,698) from $(12,068). Operating expenses declined year-over-year, but the company's balance sheet and liquidity position deteriorated materially.

• · Company generated zero revenue in both the quarter and six-month period, with no cost of revenues or gross profit.
• · Accounts receivable from related parties of $28,597 at Dec 31, 2025 was fully collected/eliminated by June 30, 2026, reducing cash-generating assets.
• · Property and equipment, net declined to $11,837 from $15,194, with accumulated depreciation and a prior litigation write-off of $235,268 referenced in the schedule.
• · Deposits received of $38,317 and advances from customers of $14,811 emerged in 2026, funding operations while accounts payable and accrued liabilities rose to $121,577.
• · Shareholder loan payable increased to $9,082 from $8,465; the company borrowed $6,169 and repaid $6,818 during the six months.
• · Foreign currency translation produced a $(1,540) comprehensive loss for six months 2026, versus a $6,608 gain in 2025.
• · No proceeds from common stock issuance in 2026, compared with $48,277 raised in the first half of 2025.
• · Going-concern pressure is implied by the stockholders' deficit of $(129,698) and a current liability base of $183,787 against current assets of only $27,239.

13-10-2026

US Nuclear Corp. (UCLE) reported sales of $352,209 thousand for the three months ended March 31, 2026, down 26.1% from $476,705 thousand a year earlier. Net loss narrowed to $187,086 thousand from $560,232 thousand, driven by a sharp drop in SG&A expenses, but the company still posted a net loss attributable to common stockholders of $275,105 thousand, and shareholders' equity remained negative at $(740,071) thousand. Revenue declined and gross profit fell 55.6% while the improvement in the bottom line relied primarily on lower operating expenses.

• · Cash fell to $67.3M at quarter end from $134.8M at the start of the period, while operating cash burn was $126.6M, funded largely by $59.1M of net financing inflows including $67.8M of net line-of-credit borrowings.
• · Accumulated deficit reached $(21,424,243) thousand, and total shareholders' equity deficit deepened from $(513.7)M to $(740.1)M in the quarter.
• · Interest paid rose to $27.3M from $10.4M year over year.
• · Anti-dilutive securities (41.4M) now exceed 60% of weighted basic shares outstanding, including 26.6M convertible preferred shares and 10.7M warrants, signaling significant potential dilution.
• · Preferred dividends were partly paid in common shares (48,725 thousand-dollar equivalent) and partly in cash ($39.3M).

13-10-2026

YAN CHUANG GROUP INC. reported a net loss of $75,448 for the twelve months ended June 30, 2026, versus $28,767 for the inception period (June 4, 2025 to June 30, 2025), with zero revenue in both periods. Total assets were $43,618 (cash only), total liabilities rose to $55,129, and stockholders' equity turned negative at $(11,511) from $21,233 a year earlier, reflecting a shell-like company with no revenue, rising liabilities including a $39,980 amount due to a director, and an accumulated deficit of $104,215.

• · Company reported zero revenue in both periods, with no operating business generating income
• · Net cash used in operating activities was $(36,419) for FY2026, funded primarily by $39,204 in common stock issuance and $3,500 in capital account changes
• · Net operating loss carryover deferred tax asset of $15,844 is fully offset by a valuation allowance, implying no recognized tax benefit
• · Quarterly net losses were $7,243 (Q1), $4,227 (Q2), $8,051 (Q3) and $55,927 (Q4) for FY2026, with Q4 accounting for roughly 74% of the annual loss

13-10-2026

BAB, Inc. (BABB) filed its quarterly report (10-Q) for the period ended August 31, 2026. Total revenue for the nine months was $2,435,220 versus $2,334,220 a year earlier (+4.3%), and for the three months it was $907,867 versus $768,533 (+18.1%). Royalty revenue rose modestly year over year (three months +3.7%, nine months +2.4%), while settlement revenue and sign shop revenue declined sharply, and gift card revenue for the nine months rose strongly.

• · Notes receivable of $49,350 are fully offset by an equal allowance for credit losses; the 60+ days past due bucket totals $32,812 with $31,995 over 90 days past due.
• · No write-offs, recoveries, or provisions for credit losses were recorded on the notes receivable allowance during the nine months ended August 31, 2026 (compared with a $974 recovery in the prior-year period).
• · Franchisee-related accounts receivable rose to $73,245 from $54,796 at November 30, 2025 (+33.7%), while vendor-related receivables declined to $19,900 from $21,550.
• · Unexpended marketing fund contributions more than doubled to $362,295 from $169,033, a key driver of the rise in current contract liabilities to $519,823.
• · Gift card liability declined to $129,923 from $168,866 at fiscal year-end, even as nine-month gift card revenue grew to $48,473 from $32,255.
• · Deferred franchise fee revenue (long-term) grew to $156,199 from $123,179.
• · Total cash and restricted cash was $2,751,005 at August 31, 2026, up from $2,426,760 a year earlier, with restricted cash of $346,329.